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Abstract
Background: Kisspeptin and its G protein-coupled receptor (GPR) 54 are essential for activation of the hypothalamo-
pituitary-gonadal axis. In the rat, the kisspeptin neurons critical for gonadotropin secretion are located in the hypothalamic
arcuate (ARC) and anteroventral periventricular (AVPV) nuclei. As the ARC is known to be the site of the gonadotropin-
releasing hormone (GnRH) pulse generator we explored whether kisspeptin-GPR54 signalling in the ARC regulates GnRH
pulses.
Methodology/Principal Findings: We examined the effects of kisspeptin-10 or a selective kisspeptin antagonist
administration intra-ARC or intra-medial preoptic area (mPOA), (which includes the AVPV), on pulsatile luteinizing
hormone (LH) secretion in the rat. Ovariectomized rats with subcutaneous 17b-estradiol capsules were chronically
implanted with bilateral intra-ARC or intra-mPOA cannulae, or intra-cerebroventricular (icv) cannulae and intravenous
catheters. Blood samples were collected every 5 min for 5–8 h for LH measurement. After 2 h of control blood sampling,
kisspeptin-10 or kisspeptin antagonist was administered via pre-implanted cannulae. Intranuclear administration of
kisspeptin-10 resulted in a dose-dependent increase in circulating levels of LH lasting approximately 1 h, before recovering
to a normal pulsatile pattern of circulating LH. Both icv and intra-ARC administration of kisspeptin antagonist suppressed LH
pulse frequency profoundly. However, intra-mPOA administration of kisspeptin antagonist did not affect pulsatile LH
secretion.
Conclusions/Significance: These data are the first to identify the arcuate nucleus as a key site for kisspeptin modulation of
LH pulse frequency, supporting the notion that kisspeptin-GPR54 signalling in this region of the mediobasal hypothalamus
is a critical neural component of the hypothalamic GnRH pulse generator.
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Introduction
Inactivating mutations of the kisspeptin receptor (GPR54) in
humans are associated with a failure to progress through puberty
and adult infertility (hypogonadotropic hypogonadism) [1,2].
Kisspeptin administration stimulates GnRH or LH secretion in
various species including mice [3], rats [4,5], sheep [6], monkeys
[7] and Humans [8]. The recent development of selective
kisspeptin antagonists [9] has facilitated investigation of the role
of endogenous kisspeptin in the control of the hypothalamo-
pituitary-gonadal axis. Central administration of the kisspeptin
antagonist, peptide 234, inhibited the post-castration rise in LH
secretion in mice, blunted the LH response to exogenous
kisspeptin in rats, suppressed LH pulse frequency and amplitude
in ewes and suppressed GnRH pulses in monkeys [9]. However,
the precise neural site of action remains to be established.
Kisspeptin perikarya are located in two discrete hypothalamic
regions in rodents; the anteroventral periventricular nucleus
(AVPV) and the arcuate nucleus (ARC) [3,10]. The AVPV sends
projections to the GnRH-rich medial preoptic area (mPOA) [11]
where kisspeptin fibers appear in close apposition to GnRH
perikarya [12]; the latter express GPR54 mRNA and show c-FOS
expression after kisspeptin administration [13].
Kisspeptin neurons in the AVPV and ARC of rodents are the
target for estrogen positive and negative feedback action
respectively, since Kiss1 mRNA expression is increased in the
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steroid [14]. Further, the LH surge is blocked by injection of
metastin antibodies into the mPOA [10] and GPR54- or
kisspeptin-null mice fail to show LH surges [15]. In contrast to
the AVPV, little is known about the role of kisspeptin-GPR54
signalling in the ARC in the regulation of gonadotropic hormone
secretion in rodents. Nevertheless, the ARC is considered to be the
prime location of the GnRH pulse generator in the rat [16], in
common with other species including primates [17].
To further explore the relationship between kisspeptin-GPR54
signalling in the control of GnRH pulse generator activity, we
examined the effects of icv administration of kisspeptin antagonist
on pulsatile LH secretion in the rat. To test the hypothesis that
kisspeptin-GPR54 signalling in the ARC plays a critical role in
controlling GnRH pulse generator activity, we examined the
effects of kisspeptin or kisspeptin antagonist microinfused into this
brain region on pulsatile LH secretion and compared the response
to microinfusion into the mPOA.
Materials and Methods
Animals and Surgical Procedures
Adult female Sprague Dawley rats (220–250 g) obtained from
Charles River (Manston, UK) were housed under controlled
conditions (12:12-h light/dark cycle with lights on at 0700 h;
temperature at 2262uC) and provided with food and water ad
libitum. All animal procedures were undertaken in accordance with
the United Kingdom Animals (Scientific Procedures) Act, 1986,
under Licence # 70/6237. Experimental procedures on animals
were also approved by the King’s College London Ethical Review
Panel Committee. Animals were allowed to habituate to the
animal unit for one week before initiation of experimentation. All
surgical procedures were carried out under ketamine anaesthesia
(100 mg/kg i.p.; Pharmacia and Upjohn Ltd., Crawley, UK) and
Rompun (10 mg/kg i.p.; Bayer, Leverkusen, Germany).
Rats were bilaterally ovariectomized and implanted with a
Silastic capsule (inner diameter, 1.57 mm; outer diameter,
3.18 mm; Sanitech, Havant, UK), filled to a length of 25 mm
with 17b-estradiol (E2) (Sigma-Aldrich, Poole, UK) dissolved at a
concentration of 20 mg/ml arachis oil (Sigma-Aldrich). The E2-
containing capsules produced circulating concentrations of E2
within the range observed during the diestrous phase of the estrous
cycle (,38.861.2 pg/ml) as previously described [18].
To evaluate the inhibitory effect of the selective kisspeptin
antagonist on pulsatile LH secretion, a group of rats was implanted
with an icv guide cannula (22 gauge; Plastics One, Roanoke, VA,
USA) directed towards the left lateral ventricle, the co-ordinates
for implantation being 0.6 mm lateral and 1.5 mm posterior to
bregma, and 4.5 mm below the surface of the dura. The guide
cannula was secured using dental cement (Dental Filling Ltd.,
Swindon, UK), and fitted with a dummy cannulae (Plastics One)
to maintain patency. To identify the neural site for kisspeptin-
GPR54 signalling to control pulsatile LH secretion, a separate
group of rats was implanted with bilateral guide cannulae (22-
gauge; Plastics One) directed at the GnRH-rich areas of the
mPOA or the ARC for microinfusion of kisspeptin or its
antagonist. The coordinates for implantation for the mPOA and
ARC cannulae were: 0.5 mm lateral, 0.26 mm posterior to
bregma and 8.6 mm below the surface of the dura, and 0.4 mm
lateral, 3.3 mm posterior to bregma, and 10.2 mm below the
surface of the dura, respectively [19]. Schematic illustration of the
microinjection sites is shown in Figure 1. The guide cannulae were
secured using dental cement (Dental Filling Ltd.) and fitted with
dummy cannulae (Plastics One). All brain cannulae were
implanted at the time of ovariectomy. After a 10-day recovery
period, the rats were fitted with two indwelling cardiac catheters
via the jugular veins. The catheters were exteriorised at the back of
the head and secured to a cranial attachment; the rats were fitted
with a 30-cm-long metal spring tether (Instec Laboratories Inc.,
Boulder, CO, USA). The distal end of the tether was attached to a
fluid swivel (Instec Laboratories), which allowed the rat freedom to
move around the enclosure. Experimentation commenced 3 day
later. Correct cannula placement in the mPOA or ARC was
confirmed by injection of 500 nl India ink through the internal
guide cannulae followed by microscopic inspection of 30 mm
frozen brain sections. Only data from animals with correct
cannula placement were analysed.
Icv Infusion of Kisspeptin or Antagonist and Pulsatile LH
Secretion
On the morning of experimentation, a single internal injection
cannula (Plastics One) with extension tubing, preloaded with a
selective kisspeptin antagonist [9] (peptide 234, 7.5 nmol in 12 ml
aCSF; N=6) or aCSF (12 ml aCSF; N=5) was inserted in the
guide cannula, extending 1.0 mm beyond its tip to reach the left
ventricle. The distal end of the tubing was extended outside of the
animal cage and attached via a dual-channel swivel (Instec
Laboratories) connected to a 25 ml Gastight Hamilton syringe
(Waters International, UK) secured in a microinjection syringe
Figure 1. Schematic illustration of the intra-cerebral microin-
jection sites. Bilateral cannulae were positioned in the medial preoptic
area (mPOA) at bregma 20.26 mm or the hypothalamic arcuate
nucleus (ARC) at bregma 23.30 mm according to the rat brain atlas of
Paxinos and Watson (19). Closed triangles represent the location of the
cannulae tips. Ac, anterior commissure; 3v, third cerebral ventricle.
doi:10.1371/journal.pone.0008334.g001
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USA) programmed to deliver 4 ml/h for 3 h, thus allowing remote
infusion without disturbing the rat during the experiment. Rats
were also attached via one of the two cardiac catheters to a
computer-controlled automated blood sampling system, which
allows for the intermittent withdrawal of small blood samples (25-
ml) without disturbing the animals. Once connected, animals were
left undisturbed for 1 h before sampling commenced. Blood
sampling commenced between 0900 and 1000 h when samples
were collected every 5 min for 8 h for LH measurement. After
removal of each 25-ml blood sample, an equal volume of
heparinized saline (5 U/ml normal saline; CP Pharmaceuticals
Ltd., Wrexham, UK) was automatically infused into the animal to
maintain patency of the catheter and blood volume. After 2 h of
controlled blood sampling, kisspeptin antagonist or aCSF were
infused in the relevant animals over a period of 3 h. Blood
sampling continued throughout the experiment. Blood samples
were frozen at 220uC for later assay to determine LH
concentrations.
Intra-ARC or Intra-mPOA Infusion of Kisspeptin-10 and
Pulsatile LH Secretion
For the administration of kisspeptin-10, bilateral injection
cannulae (Plastics One) with extension tubing preloaded with
different doses of kisspeptin-10 (Sigma-Aldrich) (1 pmol, N=6;
10 pmol, N=8; 100 pmol, N=8) in 400 nl aCSF per brain loci
(intra-ARC or mPOA) or aCSF (400 nl; N=6 for the ARC and
N=7 for the mPOA) were inserted into the guide cannulae,
extending 1.0 mm beyond its tip to reach the site of the brain
nuclei. The distal end of the tubing was extended outside of the
animal cage to allow remote infusion without disturbing the rat
during the experiment. The automated blood sampling system was
set up in the same way as described above for the collection of 25-
ml blood samples every 5 min, but only for 5 h. All treatments
were given by injection over 5 min after 2 h of the onset of blood
sampling.
Intra-mPOA or Intra-ARC Infusion of Kisspeptin
Antagonist and Pulsatile LH Secretion
For the infusion of kisspeptin antagonist into the mPOA or
ARC, internal cannulae loaded with the antagonist or aCSF were
set up in the same way as described above. Rats were
administrated with 10 pmol (mPOA, N=8; ARC, N=7 for the
ARC) or 50 pmol (mPOA, N=8; ARC, N=8) kisspeptin
antagonist in 500 nl aCSF over the period of 5 min after 2 h of
controlled blood sampling and then the same dosage was repeated
on two further occasions at an interval of 30 min. Control animals
received 500 nl aCSF only with the same regimen (mPOA, N=7;
ARC, N=6). Blood sampling procedures were set up as described
above for LH measurement.
RIA for LH Measurement
A double-antibody RIA supplied by the National Institute of
Diabetes and Digestive and Kidney Diseases was used to
determine LH concentration in the 25-ml whole blood sample
[20]. The sensitivity of the assay was 0.093 ng/ml. The intraassay
variation was 8.5% and the interassay variation was 9.5%.
Data and Statistical Analysis
Detection of LH pulse frequency and amplitude was established
by use of the algorithm ULTRA [21]. Two intra-assay coefficients
of variation of the assay were used as the reference threshold for
the pulse detection. The inhibitory effect of infusion of kisspeptin
antagonist (icv) on pulsatile LH secretion was analysed by
comparing the mean LH pulse interval before, during and after
treatments. The period duration in min of the 2 h pre-, 3 h during
and the 3 h post-treatment was divided by the number of LH
pulses detected in each of these periods to give the appropriate LH
pulse interval. When there were no LH pulses evident during the
3 h treatment period, the LH pulse interval assigned to this period
was taken as the interval from the onset of treatment to the first
LH pulse in the 3 h post-treatment period. In addition, for the icv
kisspeptin antagonist treated animals, the mean LH interpulse
interval in the pre-treatment period was compared with the post-
treatment period from the time of resumption of LH pulses
onwards. The significance of the effect of icv infusion of kisspeptin
antagonist on LH pulse intervals was also compared with their
control animals injected with aCSF alone at the same time points.
The effect of icv administration of kisspeptin antagonist on LH
pulse amplitude was compared before and during treatment only.
The effect of kisspeptin-10 administration into the ARC or mPOA
on LH secretion was calculated by comparing the area under the
LH profile in the 2 h baseline control blood sampling period to the
1 h period after administration of drug using SigmaPlot version 11
(Systat Software Inc., San Jose, CA, USA). The inhibitory effect of
administration of kisspeptin antagonist into the mPOA or ARC on
LH pulses was calculated by comparing the mean LH pulse
interval before, 1
st h and 3
rd plus 4
th h after treatment onset in
each group. For intra-mPOA and intra-ARC administration of
kisspeptin antagonist, LH pulse amplitude was compared before
and during the 1
st h after treatment onset in each group. Values
given in the text and figures represent mean 6 SEM. Comparisons
between groups were made by subjecting data to ANOVA and
Dunnett’s test.
Results
Effect of Icv Administration of Kisspeptin Antagonist on
Pulsatile LH Secretion
Pulsatile LH secretion representing normal activity of the
GnRH pulse generator was detected in both kisspeptin antagonist
and artificial cerebrospinal fluid (aCSF) treated animals during the
2-h baseline control period, with no significant difference in LH
pulse frequency between experimental groups. Kisspeptin antag-
onist profoundly suppressed pulsatile LH secretion (Fig. 2B–D;
P,0.05). LH pulses were effectively suppressed immediately after
the onset of antagonist (2.5 nmol/h) infusion in 4 out of 6 rats and
all 4 of these animals showed a complete absence of LH pulses
during the period of kisspeptin antagonist infusion (Fig. 2B). Of the
remaining animals, one displayed a single LH pulse at 50 min
from the onset of kisspeptin antagonist infusion, and the second
showed a gradual reduction in LH pulse frequency, though of
smaller amplitude during the infusion (Fig. 2C; Table 1). The
pulsatile pattern of LH secretion generally returned within 1–2 h
after the end of the kisspeptin antagonist infusion, albeit of reduced
frequency upon resumption of LH pulses (pre-treatment period
versus post-treatment period from the time of resumption of LH
pulses onwards: 26.4261.42 versus 41.0164.30 LH interpulse
interval in minutes respectively; mean 6 SEM; N=5–6; P,0.05).
Central administration of aCSF did not affect pulsatile LH
secretion (Fig. 2A and D).
Effects of Intra-ARC and Intra-mPOA Administration of
Kisspeptin-10 on LH Secretion
Both intra-ARC and intra-mPOA administration of kisspeptin-
10 resulted in a dose-dependent increase in circulating levels of LH
that lasted approximately 1 h before recovering to a normal
Kiss and GnRH Pulse Generator
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mean value of area under the LH profile during the first hour of
kisspeptin-10 infusion was significantly greater in the 100 pmol
than in the 10 pmol kisspeptin-10 treated group (Fig. 3C and F;
P,0.05). Control intra-nuclear injection of aCSF had no effect on
LH secretion (Fig. 3A and 3D).
Differential Effect of Kisspeptin Antagonist
Administration into the mPOA and the ARC on Pulsatile
LH Release
To identify the site of action for the inhibitory effect of the
kisspeptin antagonist on pulsatile LH secretion, 10 pmol or
50 pmol of the antagonist was administered into the mPOA or
ARC as 3 injections at 30 min intervals starting after 2 h baseline
control blood sampling. (Multiple injections were employed as
continual infusion was impractical in this model). Administration
of kisspeptin antagonist into the mPOA did not affect LH pulse
frequency (Fig. 4B–D) or LH pulse amplitude (Table 1). However,
intra-ARC administration of 10 pmol of antagonist suppressed LH
pulses, resulting in an immediate prolongation of LH pulse interval
(Fig. 5B–D;P ,0.05) compared with the aCSF controls, which
showed no change during the experimental period (Fig. 5A and D).
The suppression of LH pulse frequency was further enhanced in
response to the higher dose of antagonist (50 pmol63) (Fig. 5C and
D;P ,0.001). LH pulse amplitude was not affected by kisspeptin
antagonist administration into the ARC (Table 1).
Discussion
The results of this study demonstrate that administration of a
selective kisspeptin antagonist profoundly suppressed pulsatile LH
secretion in the rat. They support findings in the rhesus monkey
where stalk-median eminence perfusion of the antagonist appar-
ently suppressed GnRH pulses and in the ewe where icv infusion
of the antagonist apparently suppressed LH pulse amplitude [9].
However, as in these previous studies, it is sometimes difficult to
differentiate between amplitude and frequency effects as pulses
Figure 2. Effect of intracerebroventricular (icv) administration
of kisspeptin antagonist (Kiss-antag) on LH pulse frequency.
Representative examples illustrating the effects of continuous icv
infusion of (A) aCSF (4 ml/h for 3 h) or (B and C) Kiss-antag (2.5 nmol/h
for 3 h) in ovariectomized 17bestradiol-replaced rats. Pulsatile LH
secretion was either completely suppressed during the period of Kiss-
antag infusion (B) or LH pulse interval was significantly prolonged by
Kiss-antag (C). D, Summary showing the inhibitory effect of Kiss-antag
on pulsatile LH secretion.
{P,0.001 versus aCSF control group at the
same time point.
#P,0.001 versus Kiss-antag treated group during the
time of infusion; N=5–6 per group. *LH pulse.
doi:10.1371/journal.pone.0008334.g002
Table 1. Effect of intracerebroventricular (icv), intra-medial
preoptic area (mPOA) or intra-arcuate nucleus (ARC)
administration of kisspeptin antagonist, peptide 234 (Kiss-
antag), on LH pulse amplitude (ng/mg) in ovariectomized
17b-estradiol-replaced rats.
Treatment groups n Baseline During Post
ICV
aCSF (4 ul/h for 3 h) 5 1.9060.22 2.0160.30 2.1960.33
Kiss-antag (2.5 nmol/h for 3 h) 6 1.9160.41 1.0760.25* 2.6160.50
Intra-POA
aCSF (0.5 ul 63) 6 1.9760.29 1.9960.32 2.0360.34
Kiss-antag (10 pmol 63) 8 1.9260.17 2.0760.16 1.9760.15
Kiss-antag (50 pmol 63 ) 7 1.9660.29 1.9860.36 1.9560.25
Intra-ARC
aCSF (0.5 ul 63) 5 1.7360.33 1.7560.37 1.8060.39
Kiss-antag (10 pmol 63) 6 1.7760.54 1.8160.46 1.8760.49
Kiss-antag (50 pmol 63) 6 1.9260.27 1.8860.38 2.0460.37
*2 rats continued to show LH pulses during kisspeptin antagonist infusion/not
significant from baseline value (P=0.28).
LH pulse amplitude (Mean 6 SEM) is indicated before, during and post
administration of antagonist or artificial cerebrospinal fluid (aCSF).
doi:10.1371/journal.pone.0008334.t001
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present study, there was an immediate and complete absence of
LH pulses following icv infusion of the antagonist in 4 of the 6
animals, with the 2 remaining animals showing continuing LH
pulses with a tendency for lower amplitude (though not significant)
and with a gradual reduction in frequency. In addition, there was
a rapid restoration of LH pulses with normal pulse amplitude but
reduced frequency post-treatment. These findings suggested that
kisspeptin affects the GnRH pulse generator. However, the most
definitive evidence that the kisspeptin antagonist modulates
frequency of the GnRH pulse generator was derived from our
demonstration that intra-ARC administration reduced LH pulse
frequency in a dose-dependent manner without affecting pulse
amplitude. Interestingly, LH pulses were not affected by kisspeptin
antagonist administration into the mPOA. This differential effect
of antagonist administration into different sites of kisspeptin
neuron localization suggests that the site of action of kisspeptin in
controlling pulsatile LH secretion resides in the ARC nucleus and
not the mPOA.
The present study has provided the first direct evidence that
endogenous kisspeptin-GPR54 signalling in the ARC plays a
critical role in regulating LH pulse frequency in the rat. It is well
established that pulsatile LH secretion is governed by the GnRH
pulse generator, the precise neural construct of which still remains
to be elucidated. However, it has been proposed that kisspeptin
neurons in the ARC nucleus may represent the substrate of the
Figure 3. Effect of intra-arcuate nucleus (ARC) and intra-medial preoptic area (mPOA) administration of kisspeptin-10 (KP) on LH
secretion. Representative examples illustrating the effects of intra-ARC infusion of (A) 400 nl aCSF or (B) 100 pmol KP in ovariectomized
17bestradiol-replaced rats. C, Summary showing the effect of KP on LH secretion, calculated by comparing the mean area of under LH profile 2 h
before with 1 h after its administration. Representative examples illustrating the effects of intra-mPOA infusion of (D) 400 nl aCSF or (E) 100 pmol KP
in ovariectomized 17bestradiol-replaced rats. F, Summary showing the effect of intra-mPOA KP on LH secretion. LH secretion was dramatically
increased immediately after KP treatment in both nuclei, which lasted about 1 h in most experimental animals. *P,0.05 versus aCSF control group at
the same time point.
#P,0.05 versus 10 pmol KP treatment group at the same time point; N=5–7 per group.
doi:10.1371/journal.pone.0008334.g003
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istration of kisspeptin antagonist (Kiss-antag) on pulsatile LH
secretion. Representative examples illustrating the effects of intra-
mPOA injection of (A) of 500 nl aCSF (3 injections at 30 min intervals),
(B) 10 pmol Kiss-antag (3 injections at 30 min intervals) or (C) 50 pmol
Kiss-antag (3 injections at 30 min intervals) in ovariectomized
17bestradiol-replaced rats. D, Summary showing there was no
inhibitory effect of Kiss-antag on LH pulse interval. N=6–8 per group.
doi:10.1371/journal.pone.0008334.g004
Figure 5. Effect of intra-arcuate nucleus (ARC) administration
of kisspeptin antagonist (Kiss-antag) on pulsatile LH secretion.
Representative examples illustrating the effects of intra-ARC injection of
(A) of 500 nl aCSF (3 injections at 30 min intervals), (B) 10 pmol Kiss-
antag (3 injections at 30 min intervals) or (C) 50 pmol Kiss-antag (3
injections at 30 min intervals) in ovariectomized 17bestradiol-replaced
rats. D, Summary showing the inhibitory effect of Kiss-antag on LH
pulse frequency. *P,0.05 versus aCSF control group at the same time
point.
#P,0.001 versus Kiss-antag (10 pmol63) at the same time point;
N=5–6 per group.
doi:10.1371/journal.pone.0008334.g005
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thought to be located in the ARC nucleus of the mediobasal
hypothalamus of the rat since isolation of this region, using the
Hala ´sz deafferentation technique, permits continued follicular
growth [24] and detection of LH pulses [25]. Further, the
hypothalamic multiunit electrical activity (MUA) volleys invariably
associated with LH pulses and which provide a robust electro-
physiological correlate of GnRH pulse generator activity, are
recorded from the ARC in the rat [20,26] and goat [22]; species in
which this structure contains abundant kisspeptin neurons but is
devoid of GnRH neurons. It is worth noting that we recently
reported that intravenous administration of kisspeptin-10 elicits a
robust release of LH, and presumably GnRH, without affecting
the MUA volleys in the rat [20]; data that are seemingly
inconsistent with the notion that the MUA volleys reflect neuronal
discharge recorded from GnRH neurons per se. Interestingly, Plant
and Ramaswamy [23] have recently highlighted that the early
ARC nucleus lesioning studies in the rhesus monkey that led
Knobil to conclude that the GnRH pulse generator was located in
this hypothalamic region [17], overlapped with the now known
location of the kisspeptin perikarya [27]. The majority of the
kisspeptin neurons in the ARC would therefore have been
destroyed by the lesions, but the more laterally positioned GnRH
neural network would have been spared [27]. Although the
electrode assembly used for the MUA recordings in the monkey
were targeted to area which kisspeptin neurons are located
[27,28], they would also have encompassed the GnRH neurons
[29], so the neurochemical phenotype of the neurons that
constitute these electrophysiological correlates in the monkey still
remain an intriguing mystery. Nevertheless, Keen et al., [30]
recently demonstrated a circhoral pattern of kisspeptin release
showing 75% concordance with GnRH pulses simultaneously
measured in the stalk-median eminence in the rhesus monkey, and
that delivery of kisspeptin antagonist into the same region
suppressed GnRH pulses measured in the stalk-median eminence
dialysate [9]. Kisspeptin and its receptor are not only expressed in
the ARC but their expression here is regulated by various
physiological or pharmacological manipulations. For example,
lactating rats not only show a profound suppression of pulsatile LH
secretion, but also show a marked reduction in Kiss1 mRNA
expression [31]. Similarly, we have shown a down-regulation of
Kiss1 and GPR54 expression in the ARC in response to a variety
of different stressors and corticotropin-releasing hormone admin-
istration, which are associated with suppression of LH pulses [32].
Collectively, these findings support a role for ARC kisspeptin-
GPR54 signalling in the regulation of GnRH pulse generator
activity.
Whether kisspeptin neurons in the ARC or indeed other loci are
the key neural substrate of the GnRH pulse generator per se
remains to be established. However, with clinical observations that
patients with inactivating mutations of GPR54 exhibit low
amplitude LH pulses with approximately normal frequency
[2,33], it remains equivocal whether kisspeptin neuron input is
critical for the generation of pulsatile GnRH secretion or simply
reflects modulation of GnRH pulse amplitude [9]. Furthermore,
there is evidence that GnRH neurons themselves may be equipped
with a pulse generating mechanism. Intrinsic periodic increases in
intracellular calcium concentration synchronized with pulses of
GnRH was detected in GnRH neurons from the olfactory placode
of monkeys [34]. Episodes of spontaneous burst firing have also
been detected in green fluorescent protein identified GnRH
neurons [35].
The role of AVPV kisspeptin in GnRH surge generation is
unequivocal. These kisspeptin neurons become transcriptionally
activated at the time of the LH surge in the rat [36]. Local
injection of kisspeptin into the preoptic area induced a surge-like
increase in LH level in rats [10]. More importantly, infusion of a
specific monoclonal antibody to kisspeptin into the preoptic area
blocked the LH surge [10]. Whether the preoptic area kisspeptin-
GPR54 signaling also contributes to GnRH pulse generation is
unlikely given that in the present study intra-mPOA administra-
tion of the kisspeptin antagonist affected neither LH pulse
amplitude nor frequency. It is of note that intra-mPOA
administration of kisspeptin-10 evoked a robust release of LH,
thus it can be presumed that the antagonist delivered into this
region also has access to the kisspeptin receptor.
It is generally considered that kisspeptin directly stimulates
GnRH neurons by binding to its cognate receptor on the
perikarya. This was supported by earlier reports that both icv
and peripheral administration of kisspeptin potently increased
gonadotropic hormone secretion; an action accompanied by
induction of c-FOS activation in GnRH neurons [13,37]. More
recently, electrophysiological studies using green fluorescent
protein identified GnRH neurons in mice have shown exquisite
sensitivity to kisspeptin with sustained action potential firing
[38,39]. Further, kisspeptin antagonist was found to block
kisspeptin-10 stimulation of GnRH neuron firing [9]. However,
in contrast to rodents there are few kisspeptin-GnRH cell body
appositions in other species such as the rhesus monkey [27].
Nevertheless, there is increasing appreciation that kisspeptin may
also act at the level of the GnRH nerve terminals, where there is
close intermingling between kisspeptin and GnRH fibers at the
level of the median eminence evident in many species including
the goat [22], sheep [40] and rhesus monkey (27). Most recently,
kisspeptin was shown to stimulate GnRH release, in a GPR54-
dependent manner, from mouse mediobasal hypothalamus
explants that contain GnRH nerve terminals but lack GnRH cell
bodies [41]. Whether the marked stimulation of LH secretion
following intra-ARC administration of kisspeptin-10, as previously
shown for kisspeptin-54 [42], represents a possible local intranu-
clear effect involving an autoreceptor mediated positive feed-
forward mechanism within the ARC kisspeptin neural network
remains to be examined. Similarly, the dense plexus of kisspeptin
cell bodies and fibers in the ARC [10] and evidence of close
contacts between these fibers and cell bodies [43] may provide the
anatomical substrate for locally administered kisspeptin antagonist
to modulate LH pulse frequency. Although we cannot rule out the
possibility that the intra-ARC administration of kisspeptin
antagonist did not reach the median eminence to exert an effect
at the level of the GnRH nerve terminals, there was no evidence of
the dye injection, used to confirm cannula placement, reaching
this structure. It is also difficult to provide an explanation for the
apparent greater effect of the kisspeptin antagonist on suppression
of LH pulse frequency and the tendency to lower LH pulse
amplitude (in 2/6 animals) following icv administration compared
with intra-ARC delivery. Whether this might reflect an action of
the antagonist at the level of the median eminence following icv
infusion [44] that may not occur after intra-ARC administration
remains a possibility. However, other possible factors including
continuous versus intermittent delivery of antagonist, or the
difference in dosage of antagonist used for the icv versus intra-
ARC may contribute to different efficacy.
It was recently reported that GnRH neuron specific expression
of GPR54 in GPR54-null mice resulted in a complete rescue of
fertility [45], which might suggest that kisspeptin-GPR54 signal-
ling in the rodent ARC per se is non-essential for control of GnRH
secretion. It is difficult to reconcile these data with the present
findings of a modulatory influence of intra-ARC administration of
Kiss and GnRH Pulse Generator
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unless the antagonist was acting on GnRH nerve terminals in the
median eminence and the latter region a locus for modulation of
GnRH pulse frequency; a notion not inconsistent with the earlier
findings of Rasmussen [46] of episodic GnRH release from the rat
isolated median eminence. Further work is required to establish
the precise site of action following intra-ARC administration of
kisspeptin antagonist. Furthermore, there is always the possibility
that the kisspeptin antagonist may be acting through mechanisms
other than GPR54 receptor blockade, although there is consid-
erable evidence against this notion [9].
In summary, the present study shows that intra-ARC, but not
intra-mPOA administration of a selective kisspeptin antagonist
reduced LH pulse frequency in a dose-dependent manner without
affecting pulse amplitude in the rat. These data are the first to
identify the arcuate nucleus as a key site for kisspeptin modulation
of LH pulse frequency, supporting the notion that kisspeptin-
GPR54 signalling in this region of the mediobasal hypothalamus is
a critical neural component of the hypothalamic GnRH pulse
generator.
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